Literature DB >> 22215226

Acute bacterial prostatitis: how to prevent and manage chronic infection?

Byung Il Yoon1, Seol Kim, Dong-Seok Han, U-Syn Ha, Seung-Ju Lee, Hyun Woo Kim, Chang-Hee Han, Yong-Hyun Cho.   

Abstract

We conducted a retrospective analysis of acute bacterial prostatitis (ABP) to evaluate the factors of progressing to chronic infection and chronic pelvic pain syndrome IIIa (CPPS IIIa) from ABP. The clinical records of 480 cases compatible with a confirmed diagnosis of ABP from five urological centers between 2001 and 2010 were reviewed. We defined chronic infection (CI) as a progression to chronic bacterial prostatitis (II), epididymo-orchitis, and showing persistent pyuria and bacteriuria after treatment of ABP in admission periods when followed up at 3 months or more. Results were analyzed according to two categories: category I, developed to CI (group A, n = 49) versus recovered without CI or CPPS IIIa (group C, n = 385); and category II, developed to CPPS IIIa (group B, n = 46) versus recovered without CI or CPPS IIIa (group C, n = 385). Of the 480 ABP patients, 10.2% (49/480) progressed to CI and 9.6% (46/480) progressed to CPPS IIIa. The frequency of CI was 11.3% (49/434) and that of CPPS IIIa was 10.7% (46/431). The factors that affected progression to CI were diabetes, prior manipulation, not doing cystostomy, and urethral catheterization (P < 0.05). The factors that affected progression to CPPS IIIa were the same as CI, but prostate volume was included in the CPPS IIIa group (P < 0.05). The identification and characterization of these factors may accelerate the development of preventive, diagnostic, and therapeutic strategies for the treatment of CI and CPPS IIIa from ABP.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22215226     DOI: 10.1007/s10156-011-0350-y

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  18 in total

Review 1.  Surgical therapy of prostatitis: a systematic review.

Authors:  Dominik S Schoeb; Daniel Schlager; Martin Boeker; Ulrich Wetterauer; Martin Schoenthaler; Thomas R W Herrmann; Arkadiusz Miernik
Journal:  World J Urol       Date:  2017-06-13       Impact factor: 4.226

Review 2.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

3.  A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression.

Authors:  Brian W Simons; Nicholas M Durham; Tullia C Bruno; Joseph F Grosso; Anthony J Schaeffer; Ashley E Ross; Paula J Hurley; David M Berman; Charles G Drake; Praveen Thumbikat; Edward M Schaeffer
Journal:  J Pathol       Date:  2015-02       Impact factor: 7.996

Review 4.  Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.

Authors:  Matheus Aparecido Dos Santos Ramos; Patrícia Bento Da Silva; Larissa Spósito; Luciani Gaspar De Toledo; Bruna Vidal Bonifácio; Camila Fernanda Rodero; Karen Cristina Dos Santos; Marlus Chorilli; Taís Maria Bauab
Journal:  Int J Nanomedicine       Date:  2018-02-27

5.  Acupuncture and Traditional Chinese Medicine for the management of a 35-year-old man with chronic prostatitis with chronic pelvic pain syndrome.

Authors:  Bahia A Ohlsen
Journal:  J Chiropr Med       Date:  2013-09

6.  Tamsulosin alters levofloxacin pharmacokinetics in prostates derived from rats with acute bacterial prostatitis.

Authors:  Guo-Dong Qin; Ming-Zhao Xiao; Yuan-Da Zhou; Jing Yang; Hai-Xia He; Yue He; Yang Zeng
Journal:  Asian J Androl       Date:  2013-01-28       Impact factor: 3.285

Review 7.  Bacterial prostatitis.

Authors:  Florian M E Wagenlehner; Adrian Pilatz; Thomas Bschleipfer; Thorsten Diemer; Thomas Linn; Andreas Meinhardt; Undraga Schagdarsurengin; Temujin Dansranjavin; Hans-Christian Schuppe; Wolfgang Weidner
Journal:  World J Urol       Date:  2013-03-22       Impact factor: 4.226

8.  The Adherent/Invasive Escherichia coli Strain LF82 Invades and Persists in Human Prostate Cell Line RWPE-1, Activating a Strong Inflammatory Response.

Authors:  Maria P Conte; Marta Aleandri; Massimiliano Marazzato; Antonietta L Conte; Cecilia Ambrosi; Mauro Nicoletti; Carlo Zagaglia; Guido Gambara; Fioretta Palombi; Paola De Cesaris; Elio Ziparo; Anna T Palamara; Anna Riccioli; Catia Longhi
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

9.  Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea.

Authors:  Young Lee; Dong Gi Lee; Sang Hyub Lee; Koo Han Yoo
Journal:  J Korean Med Sci       Date:  2016-11       Impact factor: 2.153

10.  Anti-Inflammatory and Antimicrobial Effects of a Novel Herbal Formulation (WSY-1075) in a Chronic Bacterial Prostatitis Rat Model.

Authors:  Jung Woo Park; Hyun Cheol Jeong; Hyong Woo Moon; Shin Jay Cho; Jong Hyup Yang; Woo Hyun Kim; Woong Jin Bae; Jin Bong Choi; Hyuk Jin Cho; U-Syn Ha; Sung Hoo Hong; Ji Youl Lee; Sae Woong Kim
Journal:  World J Mens Health       Date:  2016-12-22       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.